Iht Wealth Management, LLC Spero Therapeutics, Inc. Transaction History

Iht Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 17, 2021	SELL	$11.65 - $22.07 $117,548 - $222,686	-10,090 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$7.27 - $14.18 $73,317 - $143,005	-10,085 Reduced 49.99%	10,090 $137,000
Q1 2020 May 13, 2020	BUY	$5.27 - $10.41 $14,018 - $27,690	2,660 Added 15.19%	20,175 $163,000
Q4 2019 Feb 18, 2020	SELL	$9.46 - $12.16 $9,460 - $12,160	-1,000 Reduced 5.4%	17,515 $168,000
Q3 2019 Nov 15, 2019	SELL	$9.01 - $12.55 $1,802 - $2,510	-200 Reduced 1.07%	18,515 $196,000
Q4 2018 Feb 15, 2019	BUY	$5.69 - $11.28 $106,488 - $211,105	18,715 New	18,715 $115,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.